Patents by Inventor Jozef Gecz

Jozef Gecz has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 10538811
    Abstract: An isolated nucleic acid molecule comprising the nucleotide sequence set forth in SEQ ID NO: 1.
    Type: Grant
    Filed: March 20, 2017
    Date of Patent: January 21, 2020
    Assignee: Central Adelaide Local Health Network Incorporated
    Inventors: Jozef Gecz, Petter Stromme
  • Publication number: 20180215803
    Abstract: Methods and kits for the diagnosis of illnesses related to protocadherin 19 (PCDH19) protein deficiency or altered PCDH19 protein function are provided, as well as methods and kits for the identification of a predisposition to such illnesses and methods of screening subjects to identify carriers of such illnesses and methods and kits for the therapeutic or prophylactic treatment of PCDH19 deficiency or altered PCDH19 protein function. Further, nucleotide and amino acid sequences corresponding to a complete PCDH19 open reading frame (ORF), mutant sequences encoding non-functional PCDH19 mRNA or altered PCDH19 mRNA are described along with transformed cells and non-human transgenic animals comprising wild-type or mutant PCDH19 ORF nucleotide sequences.
    Type: Application
    Filed: January 9, 2018
    Publication date: August 2, 2018
    Inventors: Leanne Michelle DIBBENS, Ingrid Eileen SCHEFFER, Samuel Frank BERKOVIC, John Charles MULLEY, Jozef GECZ
  • Patent number: 9873723
    Abstract: Methods and kits for the diagnosis of illnesses related to protocadherin 19 (PCDH 19) protein deficiency or altered PCDH 19 protein function, in particular EFMR (Epilepsy and Mental Retardation limited to Females) are provided, as well as methods and kits for the identification of a predisposition to such illnesses and methods of screening subjects to identify carriers of such illnesses and methods and kits for the therapeutic or prophylactic treatment of PCDH 19 deficiency or altered PCDH 19 protein function. Further, nucleotide and amino acid sequences corresponding to a complete PCDH19 open reading frame (ORF), mutant sequences encoding non-functional PCDH19 mRNA or altered PCDH19 mRN A are described along with transformed cells and non-human transgenic animals comprising wild-type or mutant PCDH19 ORF nucleotide sequences.
    Type: Grant
    Filed: January 5, 2009
    Date of Patent: January 23, 2018
    Assignees: The University of Melbourne, Central Adelaide Local Health Network Inc.
    Inventors: Leanne Michelle Dibbens, Ingrid Eileen Scheffer, Samuel Frank Berkovic, John Charles Mulley, Jozef Gecz
  • Publication number: 20170253929
    Abstract: An isolated nucleic acid molecule comprising the nucleotide sequence set forth in SEQ ID NO: 1.
    Type: Application
    Filed: March 20, 2017
    Publication date: September 7, 2017
    Inventors: Jozef Gecz, Petter Stromme
  • Patent number: 9631234
    Abstract: An isolated nucleic acid molecule comprising the nucleotide sequence set forth in SEQ ID NO: 1.
    Type: Grant
    Filed: November 30, 2012
    Date of Patent: April 25, 2017
    Assignee: Central Adelaide Local Health Network Incorporated
    Inventors: Jozef Gecz, Petter Stromme
  • Patent number: 8323885
    Abstract: An isolated nucleic acid molecule comprising the nucleotide sequence set forth in SEQ ID NO: 1.
    Type: Grant
    Filed: November 26, 2002
    Date of Patent: December 4, 2012
    Assignee: Central Adelaide Local Health Network Incorporated
    Inventors: Jozef Gecz, Petter Stromme
  • Publication number: 20110126302
    Abstract: Methods and kits for the diagnosis of illnesses related to protocadherin 19 (PCDH 19) protein deficiency or altered PCDH 19 protein function, in particular EFMR (Epilepsy and Mental Retardation limited to Females) are provided, as well as methods and kits for the identification of a predisposition to such illnesses and methods of screening subjects to identify carriers of such illnesses and methods and kits for the therapeutic or prophylactic treatment of PCDH 19 deficiency or altered PCDH 19 protein function. Further, nucleotide and amino acid sequences corresponding to a complete PCDH19 open reading frame (ORF), mutant sequences encoding non-functional PCDH19 mRNA or altered PCDH19 mRN A are described along with transformed cells and non-human transgenic animals comprising wild-type or mutant PCDH19 ORF nucleotide sequences.
    Type: Application
    Filed: January 5, 2009
    Publication date: May 26, 2011
    Inventors: Leanne Michelle Dibbens, Ingrid Eileen Scheffer, Samuel Frank Berkovic, John Charles Mulley, Jozef Gecz
  • Publication number: 20050118592
    Abstract: An isolated nucleic acid molecule comprising the nucleotide sequence set forth in SEQ ID NO: 1.
    Type: Application
    Filed: November 26, 2002
    Publication date: June 2, 2005
    Inventors: Jozef Gecz, Petter Stromme